Pharma's future

Eduardo Gotuzzo; Melissa Brosset; Camila Masias; Natalia Freundt; Maria Jose Inurritegui

Pharma's future

Eduardo Gotuzzo
, Melissa Brosset
, Camila Masias
, Natalia Freundt
, Maria Jose Inurritegui

Gotuzzo Asociados

Producción científica: Contribución a una revista › Estudio breve › revisión exhaustiva

Resumen

Latin America is an emerging region with great potential due to its short regulatory timelines, experienced sites and lower costs. As an important destination for clinical research, the region is constantly being audited by both sponsors and the FDA alike, and continues to produce excellent results.

Idioma original	Inglés
Páginas (desde-hasta)	78-81
Número de páginas	4
Publicación	European Pharmaceutical Contractor
N.º	SUMMER
Estado	Publicada - jun. 2011
Publicado de forma externa	Sí

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

@article{3a6b9879a5f64571be62ab51b0fdc3c4,

title = "Pharma's future",

abstract = "Latin America is an emerging region with great potential due to its short regulatory timelines, experienced sites and lower costs. As an important destination for clinical research, the region is constantly being audited by both sponsors and the FDA alike, and continues to produce excellent results.",

author = "Eduardo Gotuzzo and Melissa Brosset and Camila Masias and Natalia Freundt and Inurritegui, \{Maria Jose\}",

year = "2011",

month = jun,

language = "Ingl{\'e}s",

pages = "78--81",

journal = "European Pharmaceutical Contractor",

issn = "1364-369X",

number = "SUMMER",

}

TY - JOUR

T1 - Pharma's future

AU - Gotuzzo, Eduardo

AU - Brosset, Melissa

AU - Masias, Camila

AU - Freundt, Natalia

AU - Inurritegui, Maria Jose

PY - 2011/6

Y1 - 2011/6

N2 - Latin America is an emerging region with great potential due to its short regulatory timelines, experienced sites and lower costs. As an important destination for clinical research, the region is constantly being audited by both sponsors and the FDA alike, and continues to produce excellent results.

AB - Latin America is an emerging region with great potential due to its short regulatory timelines, experienced sites and lower costs. As an important destination for clinical research, the region is constantly being audited by both sponsors and the FDA alike, and continues to produce excellent results.

UR - https://www.scopus.com/pages/publications/79958185113

M3 - Estudio breve

AN - SCOPUS:79958185113

SN - 1364-369X

SP - 78

EP - 81

JO - European Pharmaceutical Contractor

JF - European Pharmaceutical Contractor

IS - SUMMER

ER -

Pharma's future

Resumen

Otros archivos y enlaces

Huella

Citar esto